Oncotelic Therapeutics, Inc. (OTLC) Gross margin
Oncotelic Therapeutics, Inc. (OTLC) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to OTLCSource: SEC XBRL filings · For reference only · Not investment advice
More OTLC financial trends
OTLC RevenueOTLC Net incomeOTLC Net marginOTLC Gross profitOTLC Operating incomeOTLC Operating marginOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Total liabilitiesOTLC Shareholders’ equityOTLC overview →